Challenges of conducting multi-center, multi-disciplinary urinary incontinence clinical trials: Experience of the Urinary Incontinence Treatment Network

Neurourology and Urodynamics

Volumn 28, Issue 3, 2009, Pages 170-176

  Steers, William ^a,c   Richter, Holly ^b   Nyberg, Leroy ^c   Kusek, John ^c   Kraus, Stephen ^d   Dandreo, Kimberly ^e   Chai, Toby ^f   Brubaker, Linda ^g  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c New England Research Institute ^*  (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e NEW ENGLAND RESEARCH INSTITUTES   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Behavioral therapy; Clinical trials; Colposuspension; Slings; Urinary incontinence; Urinary Incontinence Treatment Network

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT;

BEHAVIOR THERAPY; CLINICAL PROTOCOL; CLINICAL STUDY; CLINICAL TRIAL; COLPOSUSPENSION; GYNECOLOGIC SURGERY; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; OUTCOME ASSESSMENT; PELVIC FLOOR MUSCLE TRAINING; REVIEW; STANDARDIZATION; URINE INCONTINENCE;

CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH CARE SECTOR; HUMANS; MULTICENTER STUDIES AS TOPIC; PELVIC FLOOR; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; URINARY INCONTINENCE; UROLOGIC SURGICAL PROCEDURES; UROLOGY;

EID: 67649946805     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20653     Document Type: Review

References (29)

1. Wagner WH, Green SM, Hurt G, et al. Building a research consortium of large health systems: The cancer research network. JNCI Monographs 2005;35: 3-11.
2. Sung NS, Cowley WF, Genel M, Salber P, et al. Central challenges facing a nation clinical research enterprise. JAMA 2007;289:1278-87.
3. Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. New Engl J Med 2007;356:2143-55.
4. Zerhouni E. The NIH Roadmap. Science 2003;302:63-4.
5. Klabunde CN, Lacey LM, Kalunzy AD. Managing care in the community. In: Kalunzy AD, Warnecke RB, editors. Managing a health care alliance: Improving community cancer care. San Francisco: Jossey-Bass; 1996. pp 83-103.
6. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.
7. Veen EJ, Steenbruggen J, Roukema JA. Classifying surgical complications. Arch Surg 2005;140:1078-83.
8. Anger J, Litwin M, Wang Q, et al. Variations in stress incontinence and prolapse surgery by surgeon specialty. J Urol 2007;178:1411-7.
9. Burgio KL, Kraus SR, Menefee S, et al. Combined behavior and drug therapy enable drug discontinuation in the treatment of urge incontinence in women: A randomized controlled trial. Ann Int Med 2008;149:161-169.
10. The Urinary Incontinence Treatment Network. Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study. Contemp Clin Trials 2007;28:48-58.
11. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.
12. Schafer W, Abrams P, Liao L, et al. Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21: 261-74.
13. Nager M, Albo M, FitzGerald S, et al. Zimmern process for development of multicenter urodynamic studies. Urology 2006;69:63-7.
14. Zimmern P, Nager CW, Albo M, et al. Interrater reliability of filling cystometrogram interpretation in a multicenter study. J Urol 2006;175:2174-7.
15. Etchells E. Informed consent in surgical trials. World J Surg 1999;23:1215-9.
16. Mansbach J, Acholonu U, Sunday Clark BA, et al. Variation in institutional review board responses to a standard, observational pediatric research protocol. Soc Acad Emerg Med 2007;14:377-80.
17. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. NEJM 2001;324:424-8.
18. The Urinary Incontinence Treatment Network. Design of the SISTEr (Stress Incontinence Surgical Treatment Efficacy Trial) Study: A Randomized Surgical Trial Comparing the Burch Colposuspension and the Autologous Rectus Fascial Sling. Urology 2005;66:1213-7.
19. The Urinary Incontinence Treatment Network. The Trial of Midurethral Slings (TOMUS) Design and Durability. J Appl Res 2008 (in press).
20. Herzog AR, Diokno AC, Brown MB, et al. Two-year incidence, remisison and change patterns of urinary incontinence in noninstitutionalized older adults. J Gerontol 1990;45:M67-74.
21. Jorgensen L, Lose G, Thunedborg P. Diagnosis of mild incontinence in females: 24-hour home pad test versus the 1-hour ward test. Neurourol Urodynam 1987;6:165.
22. Wyman JF, Choi SC, Harkins SW, et al. The urinary fiary in evaluation of incontinent women: A test-retest analysis. Obstet Gynecol 1988;71:812-7.
23. Coyne KA. Summary of the validation of the OAB-q: A disease-specific overactive bladder questionnaire. Unpublished report for Pharmacia Corp (May 15, 2002). Bethesda, MD: MEDTAP International Inc.
24. Bump RC, Mattiasson A, Bo K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10-7.
25. Rogers R, Qualls C, Kammerer-Doak D, et al. Short form to assess sexual function in women with urinary incontinence and/or pelvic organ prolapse: The PISQ-11. Intl Urogyn J Pelvic Floor Dysfunct 2001;12:S2.
26. Shumaker SA, Wyman JF, Uebersax JS, et al. Health-related quality of life measures for women with urinary incontinence: The incontinence impact questionnaire and the urogenital distress inventory. Qual Life Res 1994;3: 291-306.
27. Ware JE, Kosinski M, Keller Sd. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
28. Furlong W, Feeny D, Torrance GW, Goldsmith CH, DePauw S, Zhu Z, Denton M, Boyle M. Multiplicative multi-attribute utility function for healt utilities index mark 3 (HUI3) system: A technical report. McMaster University Centre for Health Economics and Policy Analysis. 1998.
29. Avery K, Donovan J, Peters T, Shaw C, Gotoh M, Abrams P. ICI-Q: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurol Urodyn 2004;23:322-30.